Associate Director, Monitor for Nonclinical Toxicology Studies

At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

The Role & Department
The Nonclinical Safety & Toxicology Team are looking for an experienced toxicologist for a newly created position as sponsor monitor for nonclinical safety studies with Genmab’s pharmaceutical drug candidates outsourced to our CRO laboratory partners.

The Nonclinical Safety Team at Genmab is responsible for the nonclinical safety evaluation of our innovative therapeutic antibodies. At the intersection of pharmacology, immunology, toxicology, medical and regulatory sciences, and with a strong dedication to laboratory animal welfare, Nonclinical Safety & Toxicology supports the safety of patients in clinical trials with our new drug candidates or being treated with our marketed medicines.In this position you will work in close collaboration with the project toxicologists and the CRO study coordinator in our department, as well as with scientists in bioanalysis, pharmacokinetics, pharmacology, translational research, pathology, CMC, QA and other departments, to set up and oversee regulatory nonclinical safety studies performed at CROs in Europe. You will support the project toxicologists with the regulatory nonclinical safety evaluation of Genmab’s antibody-based drug candidates prior to the clinical trials.

Responsibilities include

• Work in close collaboration with the Genmab NonClinical Safety Lead/project toxicologist, other scientists, QA, and the CRO Study Director to generate GLP and non-GLP Study Plans for in vivo and in vitro nonclinical safety studies, to support FiH and later stage clinical trials and marketing of Genmab’s pharmaceutical drug candidates
• Ensure that the study designs and setup are scientifically rigorous, and in accordance with applicable regulatory and quality guidelines (ICH, regional, national, Good Laboratory Practice, and Genmab standards)
• Ensure implementation of applicable legal and company animal welfare requirements
• Coordinate safe and timely delivery/shipment of test articles/study samples with appropriate safety and quality documentation between Genmab and CRO partners
• During the conduct of the studies at CROs, be the primary Genmab sponsor contact for the CRO Study Directors
• Coordinate collaboration between the Study Director and Genmab-based Principal Investigators (bioanalysis, pharmacokinetics, etc.)
• Conduct on-site sponsor monitor visits at the CROs during in-life phases of study conduct
• On an ongoing basis monitor and evaluate observations and data from ongoing studies and communicate essential information to the project toxicologist and project team
• On behalf of Genmab, facilitate and conduct Genmab scientific review of principal investigator and study reports before finalization

Requirements

• You have a BS or MS degree in biological sciences (toxicology, pharmacology, veterinary, pathology, human biology, immunology or similar)
• You have practical experience with the scientific and regulatory development process for new pharmaceutical drug candidates, in particular with nonclinical development of biopharmaceuticals
• You have at least 5-10 years experience as a study monitor and/or study director conducting non-GLP and GLP toxicology studies, e.g. as Study Director at a CRO or in a pharma company
• You are familiar with the regulatory, legal and ethical issues relating to the use of laboratory animals
• You can analyze and present the results from complex, large datasets from toxicology studies
• Travelling regularly between EU and UK for site visits of ongoing studies
• You have excellent English written and spoken communication skills,
• You are highly proficient with the organizational tools and skills needed to lead complex projects
• You are able to work with an international and diverse team to accomplish organizational goals

This role is based in Copenhagen, Denmark and reports to the Senior Director, Non-Clinical Safety & Toxicology.

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations
Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.

Our commitment to diversity, equity, and inclusion
We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website https://www.genmab.com/privacy.

Location: Copenhagen - Carl Jacobsens Vej 30